Skip to main content
. 2012 May 11;12:174. doi: 10.1186/1471-2407-12-174

Table 2.

Baseline prevalence of comorbidity among lung cancer patients and mean survival days by comorbidity and stage of lung cancer at diagnosis

Comorbidity Stage
P-value
I
II
III
IV
N = 214 N = 104 N = 399 N = 378
 
%
Mean
%
Mean
%
Mean
%
Mean
 
Other cancer
 
 
 
 
 
 
 
 
 
 No
91.6
1235
96.2
1072
94.7
718
94.4
467
-
 Yes
8.4
1157
3.8
334
5.3
829
5.6
853
0.093
Tuberculosis
 
 
 
 
 
 
 
 
 
 No
92.5
1247
89.4
1075
90.2
743
89.4
500
-
 Yes
7.5
1002
10.6
774
9.8
553
10.6
395
0.004
COPD
 
 
 
 
 
 
 
 
 
 No
92.1
1213
94.2
1038
95.5
726
96.3
491
-
 Yes
7.9
1408
5.8
1123
4.5
685
3.7
435
<0.001
Diabetes
 
 
 
 
 
 
 
 
 
 No
86.9
1280
90.4
1065
88.7
752
88.1
492
-
 Yes
13.1
889
9.6
836
11.3
503
11.9
466
0.008
Hypertension
 
 
 
 
 
 
 
 
 
 No
70.1
1209
77.9
1111
75.4
757
73.0
498
-
 Yes 29.9 1275 22.1 806 24.6 622 27.0 465 <0.001

Mean: Average of survival days.

COPD: chronic obstructive pulmonary disease.

Missing data: 16 cases.